Choosing an SSRI in pregnancy: Clinical context versus statistical significance

Australian and New Zealand Journal of Psychiatry

Volumn 47, Issue 12, 2013, Pages 1101-1103

  Kennedy, Debra ^a  

^a ROYAL HOSPITAL FOR WOMEN   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR;

CONGENITAL MALFORMATION; FIRST TRIMESTER PREGNANCY; HEART ATRIUM SEPTUM DEFECT; HEART VENTRICLE SEPTUM DEFECT; META ANALYSIS (TOPIC); NOTE; PREGNANCY; PREGNANCY OUTCOME;

ABNORMALITIES, DRUG-INDUCED; HEART DEFECTS, CONGENITAL; HUMANS; SEROTONIN UPTAKE INHIBITORS;

EID: 84887252225     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1177/0004867413500697     Document Type: Note

References (9)

1. Eamus M, Oei J, Hill M, et al. Patterns of psychotropic drug use in pregnancy and lactation: The MotherSafe experience. Birth Defects Research. Part A, Clinical and Molecular Teratology. 2010 ; 88: 362
2. Einarson A, Pistelli A, DeSantis M, et al. Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. American Journal of Psychiatry. 2008 ; 165: 749-752
3. Kallen B, Nilsson E, Otterblad-Olausson P. Antidepressant use during pregnancy: Comparison of data obtained from a prescription database and from antenatal care records. European Journal of Clinical Pharmacology. 2011 ; 67: 839-845
4. Kennedy D. A to X: The problem of categorisation of drugs in pregnancy - An Australian perspective. Medical Journal of Australia. 2011 ; 195: 572-574
5. Mitchell AA, Gilboa SM, Werler MM, et al. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. American Journal of Obstetrics and Gynecology. 2011 ; 205: 51.e1-51.e8
6. Myles N, Newall H, Ward H, et al. Systematic meta-analysis of individual selective serotonin reuptake inhibitor medications and congenital malformations. Australian and New Zealand Journal of Psychiatry. 2013 ;:
7. Sawicki E, Stewart K, Wong S, et al. Medication use for chronic health conditions by pregnant women attending an Australian maternity hospital. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2011 ; 51: 333-338
8. Stephenson CP, Karanges E, McGregor IS. Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011. Australian and New Zealand Journal of Psychiatry. 2013 ; 47: 74-87
9. Wurst KE, Poole C, Ephross SA, et al. First trimester paroxetine use and the prevalence of congenital, specifically cardiac defects: A meta-analysis of epidemiological studies. Birth Defects Research Part A: Clinical and Molecular Teratology. 2010 ; 88: 159-170